MindWalk Holdings (HYFT) Q1 FY27 earnings call

MindWalk advanced its bio-native AI drug discovery goals in Q1 FY27, marked by the launch of its ReefIQ platform and a strategic shift towards broader platform partnerships. While significant investment in commercial infrastructure led to higher losses, the company secured a $30 million credit facility to fund growth without equity dilution. Management is focused on converting ongoing large pharma engagements for ReefIQ into recurring revenue, which is expected to be lumpy initially.